CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,431,111
- in 18 filings, $21.0M under 10b5-1 plans
Net −$21,431,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Quinlan Paul T −$2.6M General Counsel sold 49% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-09-17 | ZABRISKIE JOHN L Director | Grant or award · Stock Option (right to buy) | +7,417 | 7,417 | ||
| 2013-09-17 | Wheeler Patrick M Chief Financial Officer | Grant or award | +75,000 | $1.38 | $104K | 75,556 |
| 2013-09-17 | Wheeler Patrick M Chief Financial Officer | Grant or award · Stock Option (right to buy) | +81,856 | 81,856 | ||
| 2013-09-17 | Woosley Raymond L. Director | Grant or award · Stock Option (right to buy) | +14,750 | 14,750 | ||
| 2013-09-17 | Woosley Raymond L. Director | Grant or award · Stock Option (right to buy) | +3,463 | 3,463 | ||
| 2013-09-17 | BRISTOW MICHAEL R Pres & CEO | Grant or award | +125,000 | $1.38 | $173K | 249,778 |
| 2013-09-17 | BRISTOW MICHAEL R Pres & CEO | Grant or award · Stock Option (right to buy) | +282,825 | 282,825 | ||
| 2013-09-17 | Grais Linda S Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2013-09-17 | Grais Linda S Director | Grant or award · Stock Option (right to buy) | +7,417 | 7,417 | ||
| 2013-09-17 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +14,750 | 14,750 | ||
| 2013-09-17 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +2,608 | 2,608 | ||
| 2013-09-17 | Ozeroff Christopher David S.V.P., General Counsel | Grant or award | +75,000 | $1.38 | $104K | 92,537 |
| 2013-09-17 | Ozeroff Christopher David S.V.P., General Counsel | Grant or award · Stock Option (right to buy) | +42,642 | 42,642 | ||
| 2013-07-26 | Grais Linda S Director | Grant or award · Option to Purchase Common Stock (right to buy) | +583 | 583 | ||
| 2013-07-26 | ZABRISKIE JOHN L Director | Grant or award · Option to Purchase Common Stock (right to buy) | +583 | 583 | ||
| 2013-06-12 | BRISTOW MICHAEL R President and CEO | Conversion · Series A Convertible Preferred Stock | −781 | $160.00 | $125K | 0 |
| 2013-06-04 | BRISTOW MICHAEL R President and CEO | Grant or award · Series A Convertible Preferred Stock | +781 | $160.00 | $125K | 781 |
| 2013-06-04 | BRISTOW MICHAEL R President and CEO | Grant or award · Common Stock Warrants (right to buy) | +39,050 | 39,050 | ||
| 2013-01-25 | BRISTOW MICHAEL R President and CEO | Purchase | +1,069,290 | $0.47 | $500K | 1,069,290 |
| 2013-01-25 | BRISTOW MICHAEL R President and CEO | Purchase · Common stock warrants (right to buy) | +748,503 | 748,503 |
Page 26 of 41 · 802 trades